or
forgot password
  • cancer clinical trials in rochester, NY

  • Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Gastric Cancer
    Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
    James P. Wilmot Cancer Center
    Rochester, New York 14642
    Leukemia
    Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Head and Neck Cancer
    Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
    University of Rochester Medical Center
    Rochester, New York 14642
    Pancreatic Cancer
    Vinorelbine in Treating Children With Recurrent or Refractory Cancers
    University of Rochester Cancer Center
    Rochester, New York 14642
    Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
    Methylphenidate in Treating Patients With Melanoma
    University of Rochester Cancer Center
    Rochester, New York 14642
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
    University of Rochester Cancer Center
    Rochester, New York 14642
    Thymoma and Thymic Carcinoma
    Ifosfamide in Treating Patients With Meningeal Tumors
    James P. Wilmot Cancer Center
    Rochester, New York 14642
    Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Rhabdomyosarcoma, Adult Malignant Meningioma, Adult Brain Malignant Hemangiopericytoma
    Brachytherapy in Treating Patients With Prostate Cancer
    University of Rochester Cancer Center

    Trial Locations
    University of Rochester Cancer Center
    Genesee Hospital - Rochester
    Prostate Cancer
    High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis
    University of Rochester Cancer Center
    Rochester, New York 14642
    Multiple Myeloma and Plasma Cell Neoplasm
    Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Ovarian Cancer
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    James P. Wilmot Cancer Center
    Rochester, New York 14642
    Brain and Central Nervous System Tumors
    Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
    University of Rochester Cancer Center
    Rochester, New York 14642
    Ovarian Cancer, Testicular Germ Cell Tumor
    Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
    University of Rochester Cancer Center
    Rochester, New York 14642
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
    University of Rochester Cancer Center
    Rochester, New York 14642
    Brain and Central Nervous System Tumors
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    University of Rochester Cancer Center

    Trial Locations
    University of Rochester Cancer Center
    Genesee Hospital - Rochester
    Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Rochester General Hospital
    Rochester, New York 14621
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Anal Cancer
    Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Lung Cancer
    Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
    James P. Wilmot Cancer Center
    Rochester, New York 14642
    Sarcoma
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Quality of Life in Survivors of Gynecologic Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Endometrial Cancer, Ovarian Cancer
    Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia
    University of Rochester Cancer Center
    Rochester, New York 14642
    Leukemia
    Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Head and Neck Cancer
    Eflornithine in Treating Patients With Bladder Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Bladder Cancer
    Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
    University of Rochester Cancer Center
    Rochester, New York 14642
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    University of Rochester Cancer Center
    Rochester, New York 14642
    Diarrhea, Radiation Enteritis
    Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus
    University of Rochester Cancer Center
    Rochester, New York 14642
    Esophageal Cancer
    Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Lung Cancer
    Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
    University of Rochester Cancer Center
    Rochester, New York 14642
    Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lung Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Genesee Surgical Associates

    Trial Locations
    Genesee Surgical Associates
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Gynecologic Oncology Associates
    Breast Cancer
    Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Endometrial Cancer
    R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
    University of Rochester Cancer Center
    Rochester, New York 14642
    Leukemia
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lung Cancer
    Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
    University of Rochester Cancer Center
    Rochester, New York 14642
    Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific
    Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Prostate Cancer
    Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Combination Chemotherapy in Treating Children or Adolescents With Newly Diagnosed Stage III or Stage IV Lymphoblastic Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
    University of Rochester Cancer Center
    Rochester, New York 14642
    Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
    University of Rochester Medical Center
    Rochester, New York 14642
    Hemolytic Uremic Syndrome
    Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
    Lipson Cancer and Blood Center at Rochester General Hospital
    Rochester, New York 14621
    Lung Cancer
    Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Colorectal Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    James P. Wilmot Cancer Center
    Rochester, New York 14642
    Anemia, Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Endometrial Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Head and Neck Cancer
    Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
    University of Rochester Cancer Center
    Rochester, New York 14642
    Cardiac Toxicity, Lymphoma
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Gastrointestinal Stromal Tumor
    Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
    James P. Wilmot Cancer Center
    Rochester, New York 14642
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
    University of Rochester Cancer Center
    Rochester, New York 14642
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
    University of Rochester Cancer Center
    Rochester, New York 14642
    Cervical Cancer
    Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    University of Rochester Cancer Center
    Rochester, New York 14642
    Prostate Cancer